Moreover, transgenic mice with arterial hypertension (lacking the natriuretic peptide receptor type A) (Kilic et al., 2005) or heart failure (beta-adrenergic receptor over-expressing in the heart) (Engelhardt et al., 2002) developed cardiac hypertrophy and exhibit increased NHE-1 activity. Here, SLC9A1 is linked to cardiac hypertrophy.